Database | covid19-help.org

Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.

Substance	COVID-19 status	Phase of research	How it helps	Latest publication
Sotrovimab Mild severity	Emergency use authorization	Experimental	Antiviral	Jul/14/2022
Bamlanivimab Mild severity	Potential treatment - clinical evidence	Experimental	Antiviral	Jun/23/2022
Etesevimab Mild severity	Potential treatment - clinical evidence	Experimental	Antiviral	Jun/23/2022
Convalescent plasma Mild severity	Emergency use authorization	Experimental	Antiviral	May/16/2022
Anakinra Mild severity	Recommended by guidelines	Used to treat other disease	Other treatment	Apr/11/2022
Ivermectin Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Antiviral	Mar/30/2022
ChAdOx1 nCoV-19 Mild severity	Emergency use authorization	Experimental	Vaccine	Jan/04/2022
Tocilizumab Mild severity	Recommended by China's NHC Guidelines	Used to treat other disease	Other treatment	Dec/21/2021
Corticosteroids Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Other treatment	Dec/16/2021
Ritonavir Mild severity	Emergency use authorization	Used to treat other disease	Antiviral	Nov/02/2021
Fluvoxamine Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Other treatment	Oct/27/2021
Favipiravir Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Antiviral	Sep/24/2021
Hydroxychloroquine sulfate Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Antiviral	Apr/27/2021
Lopinavir Mild severity	Recommended by China's NHC Guidelines	Used to treat other disease	Antiviral	Apr/22/2021
Enoxaparin Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Other treatment	Apr/12/2021
Arbidol Mild severity	Recommended by China's NHC Guidelines	Used to treat other disease	Antiviral	Apr/03/2021
SinaCurcumin® Mild severity	Potential treatment - clinical evidence	Experimental	Antiviral	Mar/28/2021
Azoximer bromide Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Other treatment	Mar/25/2021
Ribavirin Mild severity	Recommended by China's NHC Guidelines	Used to treat other disease	Antiviral	Mar/25/2021
Nitazoxanide Mild severity	Potential treatment - clinical evidence	Used to treat other disease	Antiviral	Mar/16/2021

Export (.csv)